Neoadjuvant Osimertinib With/Without Chemotherapy Versus Chemotherapy Alone for <i>EGFR</i> -Mutated Resectable Non-Small-Cell Lung Cancer: NeoADAURA
-
- Masahiro Tsuboi
- National Cancer Center Hospital East, Kashiwa, Chiba277-8577, Japan
-
- Walter Weder
- Thoraxchirurgie Klinik Bethanien, Zürich, 8044, Switzerland
-
- Carles Escriu
- The Clatterbridge Cancer Centre, Bebington, Wirral, CH63 4JY, UK
-
- Collin Blakely
- Department of Medicine, University of California, San Francisco, CA94158-2140, USA
-
- Jianxing He
- The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, China
-
- Sanja Dacic
- Department of Pathology, University of Pittsburgh Medical Center, Pittsburgh, PA15213, USA
-
- Yasushi Yatabe
- National Cancer Center, Chuo-ku, Tokyo104-0045, Japan
-
- Lingmin Zeng
- AstraZeneca, Gaithersburg, MD20878, USA
-
- Andrew Walding
- AstraZeneca, Alderley Park, SK10 4TF, UK
-
- Jamie E Chaft
- Thoracic Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center & Weill Cornell Medical College, New York, NY10021, USA
Journal
-
- Future Oncology
-
Future Oncology 17 (31), 4045-4055, 2021-07-19
Informa UK Limited
- Tweet
Details 詳細情報について
-
- CRID
- 1360857593765201024
-
- ISSN
- 17448301
- 14796694
-
- Data Source
-
- Crossref
- KAKEN